Source: Sleep and Breathing Conference 2021
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Fanaridis (Heraklion, Greece), I. Bouloukaki (Heraklion, Greece), G. Stathakis (Heraklion, Greece), P. Steiropoulos (Alexandroupolisaklion, Greece), E. Mauroudi (Heraklion, Greece), V. Moniaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), S. Schiza (Heraklion, Greece). Long term effects of PAP therapy on patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) (overlap syndrome). Sleep and Breathing Conference 2021

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)” Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020 Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)? Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016 CPAP therapy in idiopathic pulmonary fibrosis (IPF) patients with obstructive sleep apnea (OSA) Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 The association of chronic obstructive pulmonary disease and sleep apnea syndrome (overlap syndrome) Source: Eur Respir J 2002; 20: Suppl. 38, 495s Year: 2002 High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate  sleep apnea  (overlap syndrome). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Cardiohemodynamics parameters in patients with COPD and obstructive sleep apnea, (OSA). Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea Year: 2017 Long-term effects of noninvasive mechanical ventilation (NMV) in COPD patients with obstructive sleep apnoea (OSA) (overlap syndrome) Source: Eur Respir J 2001; 18: Suppl. 33, 402s Year: 2001 The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010 Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD) Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies Year: 2010 Chronic respiratory failure in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Effect of melatonin on sleep quality of chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Can obstructive sleep apnea (OSA) affect the evolution of pulmonary fibrosis? A description of cases Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007 A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Natural history of idiopathic pulmonary fibrosis (IPF) associated with obstructive sleep apnea (OSA) with or without continuous positive airway pressure (CPAP) Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018